NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/16/2025
Back to search
Official data from USPTO
SANDOSTATIN LAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SANDOSTATIN LAR
ST13
US500000074478541Class
5
Filing
74478541
Registration
1904047
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
07/08/2025
Trademark type
Word
Nice classes
5
Filing date
01/11/1994
Registration date
07/11/1995
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2025
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/10/1992
First use in commerce
02/10/1992
Drawing code
1
Owner type
03
Owner location
BASEL, CH
Examiner
MANDIR, FREDERICK
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
S. C. (pessoa física)
Representatives
MAURY M. TEPPER, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
medicinal preparation useful in the management of gastrointestinal endocrine tumors
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
06/16/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/16/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/16/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
01/09/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/11/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/09/2015
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06/09/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/09/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/09/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
05/19/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/19/2009
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/02/2005
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/02/2005
PLGL
ASSIGNED TO PARALEGAL
08/17/2005
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
05/27/2005
E89R
TEAS SECTION 8 & 9 RECEIVED
05/27/2005
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2004
PAPER RECEIVED
12/06/2004
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/14/2001
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
07/09/2001
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/1995
PUBO
PUBLISHED FOR OPPOSITION
04/18/1995
NPUB
NOTICE OF PUBLICATION
03/17/1995
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/1994
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/1994
CNRT
NON-FINAL ACTION MAILED
05/27/1994
DOCK
ASSIGNED TO EXAMINER
05/26/1994
Continuous trademark protection
Get notified about every new filing that threatens SANDOSTATIN LAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.